164 related articles for article (PubMed ID: 33878964)
41. Low flow vascular malformations of the head and neck: a study on brightness mode, color coded duplex and spectral Doppler sonography.
Eivazi B; Fasunla AJ; Hundt W; Wiegand S; Teymoortash A
Eur Arch Otorhinolaryngol; 2011 Oct; 268(10):1505-11. PubMed ID: 21327731
[TBL] [Abstract][Full Text] [Related]
42. The Impact of Adjuvant Sirolimus Therapy in the Surgical Management of Scrotal Slow-Flow Vascular Malformations.
Szhafir I; Teplisky D; Lambert G; Affranchino N; Weller S; Imizcoz FL; Corbetta JP; Sierre S
Urology; 2021 Jan; 147():270-274. PubMed ID: 32920033
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.
Adams DM; Trenor CC; Hammill AM; Vinks AA; Patel MN; Chaudry G; Wentzel MS; Mobberley-Schuman PS; Campbell LM; Brookbank C; Gupta A; Chute C; Eile J; McKenna J; Merrow AC; Fei L; Hornung L; Seid M; Dasgupta AR; Dickie BH; Elluru RG; Lucky AW; Weiss B; Azizkhan RG
Pediatrics; 2016 Feb; 137(2):e20153257. PubMed ID: 26783326
[TBL] [Abstract][Full Text] [Related]
44. Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.
Sandbank S; Molho-Pessach V; Farkas A; Barzilai A; Greenberger S
Acta Derm Venereol; 2019 Oct; 99(11):990-996. PubMed ID: 31304557
[TBL] [Abstract][Full Text] [Related]
45. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
[TBL] [Abstract][Full Text] [Related]
46. [A new treatment for vascular anomalies: Six cases treated with rapamycin].
Thirion S; Jamblin P; Demarche M; Boon L; Thiry A; Hoyoux C
Arch Pediatr; 2017 Jul; 24(7):600-606. PubMed ID: 28595829
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the treatment of congenital vascular malformations using a multidisciplinary approach.
Lidsky ME; Markovic JN; Miller MJ; Shortell CK
J Vasc Surg; 2012 Nov; 56(5):1355-62; discussion 1362. PubMed ID: 22999048
[TBL] [Abstract][Full Text] [Related]
48. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH
Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641
[TBL] [Abstract][Full Text] [Related]
49. Sirolimus for the Treatment of a Massive Capillary-Lymphatico-Venous Malformation: A Case Report.
Vlahovic AM; Vlahovic NS; Haxhija EQ
Pediatrics; 2015 Aug; 136(2):e513-6. PubMed ID: 26148957
[TBL] [Abstract][Full Text] [Related]
50. Menstrual disorders associated with sirolimus treatment.
Triana P; López-Gutierrez JC
Pediatr Blood Cancer; 2021 Mar; 68(3):e28867. PubMed ID: 33369022
[TBL] [Abstract][Full Text] [Related]
51. Responsiveness of the Patient-Reported Outcome Measure for Vascular Malformation Questionnaire in Patients with Low-Flow Vascular Malformations.
Ring NY; England RW; Motaghi M; Garg T; Gong AJ; Gullotti DM; Khalil A; Bailey CR; Grossberg AL; Wu AW; Weiss CR
J Vasc Interv Radiol; 2023 May; 34(5):840-848.e5. PubMed ID: 36758741
[TBL] [Abstract][Full Text] [Related]
52. Effectiveness of sirolimus in the treatment of complex lymphatic malformations: Single center report of 56 cases.
Tian R; Liang Y; Zhang W; Wang J; Shan Y; Gao H; Xie C; Li J; Xu M; Gu S
J Pediatr Surg; 2020 Nov; 55(11):2454-2458. PubMed ID: 32044101
[TBL] [Abstract][Full Text] [Related]
53. Immunologic Effects of Sirolimus in Patients With Vascular Anomalies.
Nozawa A; Ozeki M; Yasue S; Endo S; Kawamoto N; Ohnishi H; Fumino S; Furukawa T; Tajiri T; Maekawa T; Fujino A; Souzaki R; Fukao T
J Pediatr Hematol Oncol; 2020 Jul; 42(5):e355-e360. PubMed ID: 31743321
[TBL] [Abstract][Full Text] [Related]
54. Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment.
Salloum R; Fox CE; Alvarez-Allende CR; Hammill AM; Dasgupta R; Dickie BH; Mobberley-Schuman P; Wentzel MS; Chute C; Kaul A; Patel M; Merrow AC; Gupta A; Whitworth JR; Adams DM
Pediatr Blood Cancer; 2016 Nov; 63(11):1911-4. PubMed ID: 27273326
[TBL] [Abstract][Full Text] [Related]
55. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
Durand R; Reid JR; Belasco JB; Shellikeri S; Calle-Toro JS; Cahill AM; Srinivasan A
AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
[No Abstract] [Full Text] [Related]
56. Effects of physiotherapy combined with sirolimus in a patient with vascular malformation: A case report.
Akbayrak T; Orhan C; Baran E; Kaya S; Coskun G; Varan A
Turk J Pediatr; 2016; 58(2):203-207. PubMed ID: 27976563
[TBL] [Abstract][Full Text] [Related]
57. Sirolimus experience in adult patients with vascular malformations.
Akyildiz A; Ismayilov R; Guven DC; Yildirim HC; Tatar OD; Kus F; Chalabiyev E; Turker FA; Dizdar O; Yalcin S; Gullu HI
Vascular; 2024 Mar; ():17085381241241853. PubMed ID: 38523367
[TBL] [Abstract][Full Text] [Related]
58. Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl.
Cardis MA; DeKlotz CMC
Pediatr Dermatol; 2018 Nov; 35(6):e406-e407. PubMed ID: 30152558
[TBL] [Abstract][Full Text] [Related]
59. Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol.
Weitz-Tuoretmaa A; Keski-Nisula L; Rautio R; Laranne J
Acta Radiol; 2018 Aug; 59(8):946-952. PubMed ID: 29124942
[TBL] [Abstract][Full Text] [Related]
60. Novel treatment of recurrent orbital venolymphatic malformation with sirolimus and rivaroxaban.
Purt B; Rana HS; Whitescarver TD; Chou E
Orbit; 2022 Dec; 41(6):771-778. PubMed ID: 34030590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
